A randomized controlled trial of a proactive analgesic protocol demonstrates reduced opioid use among hospitalized adults with inflammatory bowel disease

A randomized controlled trial of a proactive analgesic protocol demonstrates reduced opioid use among hospitalized adults with inflammatory bowel disease

Abstract Most hospitalized patients with inflammatory bowel disease (IBD) experience pain. Despite the known risks associated with opioids in IBD including risk for misuse, overdose, infection, readmission, and even death, opioid use is more prevalent in IBD than any other chronic gastrointestinal c...

Full description

Bibliographic Details
Main Authors: Sameer K. Berry, Will Takakura, Devin Patel, Rajalakshmi Govalan, Afsoon Ghafari, Elizabeth Kiefer, Shao-Chi Huang, Catherine Bresee, Teryl K. Nuckols, Gil Y. Melmed
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48126-0

Internet

https://doi.org/10.1038/s41598-023-48126-0

Similar Items